[330 Pages Report] The global cryopreservation for IVF market has witnessed a moderate drop in 2020, attributed to the ongoing coronavirus pandemic. Restrictions on production facilities, and reduced consumer expenditure on the sector has hurt market prospects for the short term.
As per the latest market study by Future Market Insights (FMI), the cryopreservation for IVF market is expected to grow at an impressive 10.2% CAGR through 2030. According to the report, innovations in terms of vitrification processes, especially for oocyte preservation aids market developments.
Despite the strong growth of cryogenics in the healthcare sector, prohibitive costs and strict rules on IVF treatments, coupled with complexities and limitations of tech in the market hold back growth.
Key Takeaways on Cryopreservation for IVF Market
- The cryopreservation for IVF market size surpassed US$ 339 Mn in 2019, with market growth witnessing a moderate slump throughout the duration of the covid-19 outbreak, as lockdown restrictions hinder supply chains, and consumers redirect expenses towards essential commodities.
- IVF clinics will continue as the leading user of cryogenics in IVF treatments, the segment is projected to account for more than 60% of the overall market share over the forecast period.
- Cryogenic liquid cylinders are witnessing high demand in the cryopreservation for IVF market, aided by the wide scope of application in vitrification processes.
- East Asia will remain a leading regional market for cryopreservation in IVF centres, supported by relatively lower costs of healthcare and positive changes to population policies. Also, Latin America is expected to display strong growth owing to research applications.
To remain ahead of your competitors, request for a sample - https://www.futuremarketinsights.com/reports/sample/rep-gb-12785
"Higher rates of infertility have become a global issue. Strict regulations in numerous countries restrict couples from choosing fertility treatment, which has pushed couples to seek treatment in other regions bolstering to fertility tourism. With reductions in costs of cryogenics this factor will positively influence market developments," said a lead analyst from FMI.
Covid-19 Effects on Cryopreservation for IVF MarketThe cryopreservation for IVF sector has been negatively impacted by the ongoing covid-19 pandemic. Concerns over procedures and precautions in terms of handling seropositive patients are influencing short-term developments. Also, the risk of cross contamination and viral transmission during cryogenic procedures will limit adoption during this period.
Cryogenic device production facilities have been affected by lockdown regulations, while restrictions on elective medical procedures have also hurt market developments. The market is expected to recover towards 2021 with rebounding consumer spending on cryogenics and IVF treatments in the post-pandemic era.
Ask from Market Research Expert - https://www.futuremarketinsights.com/ask-question/rep-gb-12785
Who is Winning?
In a recent report, Future Market Insights has provided a detailed overview of the varying business strategies that find use in the cryopreservation for IVF market. Leading players in the sector have invested in the development and launch of new product offerings, with the incorporation of cutting-edge tech. Strategic collaborations and acquisitions are also gaining popularity in the industry.
Thermo Fisher Scientific Inc., Millipore Sigma, Fujifilm Irvine Scientific Inc., Vitrolife AB, Kitazato Corp., Brooks Life Sciences, Corning Inc., Worthington Industries Inc., Cook Medical LLC, are the most prominent players in the market.
Key SegmentsProduct Type
- Cryopreservation Media
- Cryopreservation Storage Devices
- Cryogenic Liquid Cylinders
- Cryogenic Storage Tanks
- Vapor Tanks
- Storage Alarm Systems
- LN 2 Auto Fill Systems
- LN2 Sterilization System
- Cryo Control/Inventory Management Systems
- Storage Container
- Consumables & Accessories
- Vitrification Carriers
- Sperm Straws
- Saw Freeze Straws
- Dry Shipper Container
- Clinical Pack Over Wrap
- Cryogenic Labels
For in-depth insights, Download a PDF Brochure - https://www.futuremarketinsights.com/reports/brochure/rep-gb-12785
- Oocycte Cryopreservation
- Sperm Cryopreservation
- Embryo Cryopreservation
- IVF & Fertility Clinics
- Research & Academic Institutes
- Cryo Monitoring /Inventory Management
- North America (US, Canada)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- Europe (Germany, UK, Russia, France, Italy, Spain, BENELUX, Rest of Europe)
- South Asia (India, Thailand, Indonesia, Malaysia, Rest of South Asia)
- East Asia (China, Japan, and South Korea)
- Oceania (Australia, New Zealand)
- Middle East & Africa (GCC Countries, Turkey, South Africa, and Rest of MEA)
More Trending Reports by Future Market Research :
Nasal Antihistamines Market Type : The global Nasal Antihistamines Market was valued at US$ 1.8 Bn in 2020 and is expected to register a CAGR of 4.6% during the forecast period (2021-2031).
Manometry System Market Forecast : Sales of global manometry systems market totaled US$ 157.3 Mn in 2020. The market registered positive growth at 5.4% CAGR, reaching a valuation of US$ 279.6 Mn by the end of 2031, according to Future Market Insights' (FMI's) latest study.
Active Humidifier Devices Market Trends : Global Active Humidifier Devices Market was valued at US$ 1.2 Bn in 2020 and is expected to surpass US$ 1.1 Bn by 2031
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
United Arab Emirates
For Sales Enquiries: email@example.com
This content is published on behalf of the above source. Please contact them directly for any concern related to the above.
This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.